Related Articles
Programmed death ligand 1 expression in esophageal cancer following definitive chemoradiotherapy: Prognostic significance and association with inflammatory biomarkers
WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer
Impact of antiretroviral drugs on PD‑L1 expression and copy number gains with clinical outcomes in HIV‑positive and ‑negative locally advanced cervical cancers
Intensity‑modulated radiotherapy for synchronous cancer of the anal canal and cervix
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes